Timothy Henrich, MD
Enriched profileProfessor of Medicine, University of California, San Francisco · University of California, San Francisco
Timothy Henrich is Professor of Medicine, University of California, San Francisco at University of California, San Francisco. OpenAlex indexes 236 publications with 11,074 citations (h-index 53); ClinicalTrials.gov lists 7 registered studies with this person as an investigator.
Data verified 17 Aug 2026
Overview
Updated 27 Aug 2026
Timothy Henrich, M.D., is Professor of Medicine, University of California, San Francisco. The public record shows 236 publications with 11,074 citations (h-index 53), centered on HIV Research and Treatment, Long-Term Effects of COVID-19, COVID-19 Clinical Research Studies. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 4 companies, 17 NIH-funded awards (2015–2026).
- Most recent indexed publication: 2026 · International journal of molecular sciences
- Top research focus: HIV Research and Treatment
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 4 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 16 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 124.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Multiparametric [18F]F-AraG Imaging in Post-Acute Sequelae of COVID-19 (PASC)
Sponsor: University of California, Davis
- Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID
Sponsor: Timothy Henrich
- Imaging Immune Activation in COVID-19
Sponsor: CellSight Technologies, Inc.
Industry payments
Updated 27 Aug 2026
4 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- IMMUNITYBIO, INC.Program year20251 payment
- F. Hoffmann-La Roche AGProgram year20221 payment
- Regeneron Pharmaceuticals, Inc.Program year20222 payments
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
47.4%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor21.2%Tivicay100%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor17.5%Descovy100%Part D<11 patientsCardiovascular
24.8%Statin14.6%Atorvastatin Calcium100%Part D<11 patientsCalcium channel blocker10.2%Amlodipine Besylate100%Part D<11 patientsRespiratory
17.5%Corticosteroid8.8%Fluticasone Propionate100%Part D<11 patientsbeta2-Adrenergic Agonist8.8%Ventolin Hfa100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
17 NIH research awards on record, funded 2015–2026 per NIH RePORTER. The latest:
- In Vivo Imaging and Post-Mortem Study of Methamphetamine Use on Immune Dysfunction and HIV Reservoir Transcription among People with HIV on ART
University of California, San Francisco
FY2026$2,335,360RM1DA063218 - Early antiviral treatment to prevent viral persistence and inflammation as drivers of Long COVID: a proof-of-concept mechanistic trial
University of California, San Francisco
FY2026$1,663,160U01AI192043 - In situ spatial characterization of CNS HIV-host cellular interactions from victims of sudden death
University of California, San Francisco
FY2026$491,962R61DA061826
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Increased Mannosylation of Extracellular Vesicles in Long COVID Plasma as a Binding Target for Galanthus nivalis Agglutinin (GNA) Affinity Resin.
International journal of molecular sciences
Article2026
Most-cited works
by citation count (OpenAlex)- 01Development of a Definition of Postacute Sequelae of SARS-CoV-2 InfectionArticle867 citations2023
- 02International AIDS Society global scientific strategy: towards an HIV cure 2016Article429 citations2016
- 03HIV-1 persistence in CD4+ T cells with stem cell–like propertiesArticle416 citations2014
- 04Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell TransplantationArticle403 citations2014
- 05Serotonin reduction in post-acute sequelae of viral infectionArticle365 citations2023
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- LinkedIn
linkedin.com/in/timothy-henrich-694b3111
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Timothy-J-Henrich-15530967
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
polybio.org/interviews/polybios-dr-amy-proal-interviews-dr-tim-henrich-on-imaging-deep-tissue-sars-cov-2-reservoirs-in-longcovid
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →polybio.org ↗ - Other
tlcsessions.net/episodes/episode-69-prof-tim-henrich-viral-persistence-and-t-cell-dysregulation
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →tlcsessions.net ↗ - X / Twitter
x.com/polybioRF/status/1989451996722852045
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
Editorial & leadership roles
journal and society appointments- Fellow
Infectious Diseases Society of America (FIDSA)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →idsociety.org ↗ - Director
UCSF CIDMI
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cidmi.ucsf.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cfar.ucsf.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →experimentalmedicine.ucsf.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cidmi.ucsf.edu ↗
Media & interviews
press, podcasts and appearances- Named source/quoted
"First person may be cured of HIV after stem cell transplant without CCR5 mutation," aidsmap
2023provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aidsmap.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →croiwebcasts.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →positivelyaware.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Kristine Yaffe, MD
University of California, San Francisco
Peter Carroll, MD
University of California, San Francisco
Mitchel Berger, MD
University of California, San Francisco
Elyse Foster, MD
University of California, San Francisco